| |
IRD (N = 127)
|
RD (N = 217)
|
p1
|
|---|
|
Maximal treatment response, n (%)
|
n = 126
|
n = 216
| |
|
sCR
|
2 (1.6%)
|
–
|
0.095
|
|
CR
|
12 (9.5%)
|
19 (8.8%)
|
|
VGPR
|
28 (22.2%)
|
30 (13.9%)
|
|
PR
|
50 (39.7%)
|
94 (43.5%)
|
|
MR
|
11 (8.7%)
|
34 (15.7%)
|
|
SD
|
13 (10.3%)
|
17 (7.9%)
|
|
PD
|
10 (7.9%)
|
22 (10.2%)
|
|
VGPR+ a
|
42 (33.3%)
|
49 (22.7%)
|
0.042
|
|
ORRb
|
92 (73.0%)
|
143 (66.2%)
|
0.227
|
|
CBRc
|
103 (81.7%)
|
177 (81.9%)
|
1.000
|
- a VGPR+ − patients reaching at least very good partial response
- b ORR – Overall Response Rate (PR or better)
- c CBR – Clinical Benefit Rate (MR or better)
- 1 p-value of Fisher’s exact test
